Published in Life Sci on January 26, 1987
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev (2009) 3.08
The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Deliv Rev (1995) 2.03
Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int J Nanomedicine (2007) 1.41
Epirubicin-adsorbed nanodiamonds kill chemoresistant hepatic cancer stem cells. ACS Nano (2014) 0.97
Enhanced passive pulmonary targeting and retention of PEGylated rigid microparticles in rats. Int J Pharm (2010) 0.94
Protein Adsorption Patterns and Analysis on IV Nanoemulsions-The Key Factor Determining the Organ Distribution. Pharmaceutics (2012) 0.78
Novel drug delivery systems: desired feat for tuberculosis. J Adv Pharm Technol Res (2010) 0.75
Nanostructured Biomaterials and Their Applications. Nanomaterials (Basel) (2013) 0.75
Home monitoring of blood glucose using filter paper strips. Br Med J (1979) 2.86
A scoring error in the Mini-Mental State test. Can J Psychiatry (1993) 2.69
Patterns of class inequality in health through the lifespan: class gradients at 15, 35 and 55 years in the west of Scotland. Soc Sci Med (1994) 2.58
Transit of pharmaceutical dosage forms through the small intestine. Gut (1986) 2.35
Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life. Thorax (2004) 2.22
Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev (2004) 2.10
PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release (1999) 2.08
FTIR microscopic imaging of collagen and proteoglycan in bovine cartilage. Biopolymers (2001) 2.07
Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer. J Clin Oncol (2005) 2.04
Chitosan as a novel nasal delivery system for vaccines. Adv Drug Deliv Rev (2001) 1.87
Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption. Int J Pharm (2000) 1.73
The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomatic. Ann Neurol (1992) 1.67
Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm Res (1994) 1.61
PET demonstrates reduced dopamine transporter expression in PD with dyskinesias. Neurology (2008) 1.60
Nurse practitioners: the South Thames RHA experience. Nurs Times (1995) 1.60
Sleep, arousals, and oxygen desaturation in chronic obstructive pulmonary disease. The effect of oxygen therapy. Am Rev Respir Dis (1982) 1.58
Evaluation of impotence in older men. West J Med (1985) 1.54
The preparation and characterization of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharm Res (1993) 1.53
Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics. J Biomed Mater Res (1998) 1.51
Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. Biochem Biophys Res Commun (1991) 1.50
Receiver operating characteristic curve analysis in the prediction of carpal tunnel syndrome: a model for reporting electrophysiological data. Muscle Nerve (1993) 1.48
Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase. Eur J Pharm Biopharm (1999) 1.42
Nanoparticles in drug delivery. Crit Rev Ther Drug Carrier Syst (1987) 1.42
Heavy metals in some Asian medicines and cosmetics. Public Health (1979) 1.42
Protriptyline in obstructive sleep apnea: a double-blind trial. N Engl J Med (1982) 1.41
Saccadic strategies in children with hemianopia. Dev Med Child Neurol (1998) 1.40
Hodgkin's disease presenting as an enlarged thyroid gland. Report of a case diagnosed by fine needle aspiration. Acta Cytol (1991) 1.40
Physicochemical properties of parenteral fat emulsions containing 20% triglyceride; Intralipid and Ivelip. J Clin Pharm Ther (1993) 1.40
Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study. Brain (2009) 1.40
Automated conductimetric titrimeter: use in studying ionic solute-solute interactions. J Pharm Sci (1975) 1.39
Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers. Pharm Res (1994) 1.37
Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm (2004) 1.37
Influence of dingoes on sheep distribution in Australia. Aust Vet J (2013) 1.36
Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens. Infect Immun (2000) 1.35
Like parent like child? Associations between drinking and smoking behaviour of parents and their children. Br J Addict (1991) 1.33
Lack of class variation in health in adolescence: an artefact of an occupational measure of social class? Soc Sci Med (1991) 1.31
Chitosan as a novel nasal delivery system for peptide drugs. Pharm Res (1994) 1.30
Evaluation of the clearance characteristics of bioadhesive systems in humans. Int J Pharm (1999) 1.30
Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers. J Pharm Sci (1997) 1.28
Colloidal carriers for intravenous drug targeting: plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis (1993) 1.27
Poor recall, misunderstandings and embarrassment: interpreting discrepancies in young men's reported heterosexual behaviour. Cult Health Sex (1999) 1.27
A pilot study on the use of botulinum toxin in spasmodic torticollis. Can J Neurol Sci (1985) 1.26
Reporting by parents of longstanding illness in their adolescent children. Soc Sci Med (1993) 1.24
Correlates of blood pressure in 15 year olds in the west of Scotland. J Epidemiol Community Health (1991) 1.24
Biodegradable microparticles as controlled release antigen delivery systems. Immunology (1991) 1.24
Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection. Crit Rev Ther Drug Carrier Syst (1994) 1.21
Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects. Pharm Res (1991) 1.20
Chitosan microspheres prepared by spray drying. Int J Pharm (1999) 1.20
Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation. J Control Release (2001) 1.20
Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen. Immunology (1992) 1.19
Microparticles as potentially orally active immunological adjuvants. Vaccine (1989) 1.19
Mortality indices in resource allocation. Community Med (1979) 1.19
Wound infection caused by Kanagawa-negative Vibrio parahaemolyticus. J Clin Microbiol (1984) 1.18
Progression of dopaminergic dysfunction in a LRRK2 kindred: a multitracer PET study. Neurology (2008) 1.18
Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism. Ann Neurol (1994) 1.17
Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration. J Control Release (2002) 1.17
The polyoxyethylene/polyoxypropylene block co-polymer poloxamer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow. FEBS Lett (1992) 1.17
Sleep breathing abnormalities in kyphoscoliosis. Am Rev Respir Dis (1980) 1.17
Secondary hypogonadism in older men: its relation to impotence. J Clin Endocrinol Metab (1990) 1.16
Health at age 11: reports from schoolchildren and their parents. Arch Dis Child (1998) 1.16
Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles. Biomaterials (1999) 1.16
Reassessment of unilateral pallidotomy in Parkinson's disease. A 2-year follow-up study. Brain (1999) 1.15
Duration of amyotrophic lateral sclerosis is age dependent. Muscle Nerve (1993) 1.14
Incidence and prevalence of copper deficiency following roux-en-y gastric bypass surgery. Int J Obes (Lond) (2011) 1.14
Compliance in medication by Asian immigrants. Nurs Times (1979) 1.13
Lead poisoning and traditional practices: the consequences for world health. A study in Kuwait. Public Health (1981) 1.13
Microfilament dysfunction as a possible cause of intrahepatic cholestasis. Gastroenterology (1975) 1.13
Family life and health in adolescence: a role for culture in the health inequalities debate? Soc Sci Med (1995) 1.12
Transport of nanoparticles across the rat nasal mucosa. J Drug Target (2001) 1.11
Informational needs of women with a recent diagnosis of breast cancer: development and initial testing of a tool. J Adv Nurs (1997) 1.11
Age-dependent decline of dopamine D1 receptors in human brain: a PET study. Synapse (1998) 1.10
Alcohol-related aggression in the general population. J Stud Alcohol (2000) 1.10
Morphine kinetics after diamorphine infusion in premature neonates. Br J Clin Pharmacol (1991) 1.09
Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake. Pharm Res (1997) 1.08
Socio-demographic correlates of dietary habits in mid to late adolescence. Eur J Clin Nutr (1994) 1.08
Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. Biochim Biophys Acta (1993) 1.08
Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles. Pharm Res (2002) 1.08
Catalytically inactive protein phosphatase 2A can bind to polyomavirus middle tumor antigen and support complex formation with pp60(c-src). J Virol (1999) 1.07
Information needs of women during early treatment for breast cancer. J Adv Nurs (1997) 1.07
Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method. J Drug Target (1993) 1.07
Polylactide-poly(ethylene glycol) micellar-like particles as potential drug carriers: production, colloidal properties and biological performance. J Drug Target (2001) 1.07
Lipid emulsions as drug delivery systems. Ann N Y Acad Sci (1987) 1.07
Epi-fluorescence microscopy and image analysis used to measure diffusion coefficients in gel systems. J Pharm Pharmacol (1992) 1.06
Defining the drug incorporation properties of PLA-PEG nanoparticles. Int J Pharm (2000) 1.06